Viewing Study NCT03259503


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-03-16 @ 10:59 PM
Study NCT ID: NCT03259503
Status: COMPLETED
Last Update Posted: 2025-11-10
First Post: 2017-08-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Diffuse Large B-Cell Lymphoma View
None Recurrent T-Cell Non-Hodgkin Lymphoma View
None Refractory Diffuse Large B-Cell Lymphoma View
None Refractory Hodgkin Lymphoma View
None Refractory T-Cell Non-Hodgkin Lymphoma View
Keywords: